Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis

QR Code

Role of blood cholesterol transport system disturbances in atherosclerosis development in rheumatoid arthritis

Objective. To study role of inflammation and disturbances of blood cholesterol transport system in atherosclerotic damage development in rheumatoid arthritis (RA). Material and methods. 84 RA pts with mean age 48 years and mean disease duration 87 months were included. Control group consisted of 15...

Full description

Saved in:

Bibliographic Details
Main Authors:	T. V. Popkova, D S Novikova, A A Novikov, E N Alexandrova, E S Mach, T N Gawa, A. V. Masova, L A Gracheva, A A Bologov, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2007-10-01
Series:	Научно-практическая ревматология
Subjects:	inflammation rheumatoid arthritis atherosclerosis lipoprotein
Online Access:	https://rsp.mediar-press.net/rsp/article/view/298
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PROATHEROGENIC LIPID AND LIPOPROTEIN METABOLIC DISTURBANCES IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E. V. Gerasimova, et al.
Published: (2017-07-01)

Features of lipid metabolism disturbances in patients with rheumatoid arthritis
by: A E Sizikov, et al.
Published: (2009-04-01)

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis
by: Elena Vasilyevna Udachkina, et al.
Published: (2013-10-01)

SPECIFICS OF SUBFRACTIONAL SPECTRUM OF APOLIPOPROTEIN B RELATED LIPOPROTEINES IN CAROTID OR CORONARY ATHEROSCLEROSIS PATIENTS
by: N. E. Gavrilova, et al.
Published: (2016-10-01)

Peripheral plaque burden in the diagnosis of coronary atherosclerosis in rheumatoid arthritis
by: O. A. Fomicheva, et al.
Published: (2024-10-01)

Lipoprotein(a), homocysteine and coronary atherosclerosis in young and middle-aged men
by: M. V. Ezhov, et al.
Published: (2008-10-01)

Role of interleukin 1 in the development of atherosclerosis
by: E. L. Nasonov, et al.
Published: (2019-04-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

PREDICTION OF MULTIFOCAL ATHEROSCLEROSIS IN WOMEN WITH RHEUMATOID ARTHRITIS
by: I. V. Osipova, et al.
Published: (2018-06-01)

ANTI-INFLAMMATORY THERAPY FOR ATHEROSCLEROSIS: CONTRIBUTION TO AND LESSONS OF RHEUMATOLOGY
by: E. L. Nasonov, et al.
Published: (2017-10-01)

Cholesterol of Low-Density Lipoprotein-Containing Circulating Immune Complexes Improves Prognosis of Asymptomatic Carotid Atherosclerosis
by: A. N. Orekhov, et al.
Published: (2024-06-01)

EFFECT OF RITUXIMAB ON THE BLOOD CHOLESTEROL TRANSPORT SYSTEM IN PATIENTSWITH RHEUMATOID ARTHRITIS
by: Tatyana Valentinovna Popkova, et al.
Published: (2010-08-01)

Atherosclerosis and inflammation – from pathogenesis to treatment: current state of affairs (Part I)
by: A. A. Avagimyan, et al.
Published: (2025-04-01)

Relationship between C-reactive protein concentration, bone mineral density and cardiovascular disturbances in patients with rheumatoid arthritis
by: T. N. Gavva, et al.
Published: (2008-06-01)

Aggressive course of atherosclerosis in hyperlipoproteinemia (a): a case series
by: A. M. Namitokov, et al.
Published: (2023-12-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

CARDIOVASCULAR RISK ASSESSMENT IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS WITHIN THE REMARCA STUDY: PRELIMINARY DATA
by: D. S. Novikova, et al.
Published: (2015-03-01)

Statin therapy and atherosclerosis regression
by: A. V. Susekov
Published: (1970-01-01)

Eurasian Association of Cardiology (EAC)/ Russian National Atherosclerosis Society (RNAS) Guidelines for the diagnosis and correction of dyslipidemia for the prevention and treatment of atherosclerosis (2025)
by: M. V. Ezhov, et al.
Published: (2025-06-01)

CHARACTERISTICS OF CORONARY ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: V. A. Azizov, et al.
Published: (2015-06-01)

Lipoprotein(a), atherosclerosis and cardiovascular risk
by: E. A. Polyakova, et al.
Published: (2024-12-01)

PROGRESSION OF CAROTID ARTERY ATHEROSCLEROSIS DURING TREATMENT TO TARGET IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
by: E. V. Udachkina, et al.
Published: (2018-09-01)

EFFECT OF SIMVASTATIN THERAPY UPON IMMUNOLOGICAL MARKERS OF ATHEROSCLEROSIS IN THE PATIENTS WITH RHEUMATOID ARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2014-07-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Cardiovascular disturbances and atherosclerosis risk Гасtore in systemic lupus erythematosus
by: T V Popkova, et al.
Published: (2004-08-01)

Lipoprotein(a) and Blood Monocytes as Factors for Progression of Carotid Atherosclerosis in Patients with Premature Coronary Heart Disease
by: Alexandra V. Tyurina, et al.
Published: (2025-06-01)

Contradictions in traditional ideas about atherosclerosis and the efficacy of lipid-lowering therapy. Promising directions
by: A. P. Vasiliev, et al.
Published: (2024-08-01)

Risk factors of cardiovascular diseases in rheumatoid arthritis
by: T V Popkova, et al.
Published: (2009-06-01)

TIME COURSE OF CHANGES IN BLOOD LIPID PARAMETERS IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING TREAT-TO-TARGET ANTIRHEUMATIC THERAPY: ACCORDING TO 18-MONTH FOLLOW-UP FINDINGS
by: E. V. Udachkina, et al.
Published: (2016-07-01)

Traditional cardiovascular risk factors and atherosclerosis in patients with systemic sclerosis
by: S. S. Shabanova, et al.
Published: (2016-05-01)

Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease
by: A. E. Nikitin, et al.
Published: (2020-03-01)

Lipoprotein (a) polymorphism as a risk factor of coronary and carotid atherosclerosis and its complications in women
by: O. I. Afanasyeva, et al.
Published: (2010-12-01)

Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01)

Lipoprotein(a) as a factor in the severity of vascular events in patients with ischemic stroke, stage 3 hypertension and multifocal atherosclerosis
by: S. S. Vedenskaya, et al.
Published: (2025-03-01)

Rheumatoid arthritis and cardiovascular diseases: close relatives or friends?
by: A. V. Gordeev, et al.
Published: (2023-04-01)

SUBFRACTION DISTRIBUTION OF APO B-CONTAINING LIPOPROTEINS DEPENDING ON THE ACHIEVEMENT OF THE TARGET LEVEL OF LOW DENSITY LIPOPROTEINS UNDER STATINS THERAPY IN PATIENTS WITH CORONARY ATHEROSCLEROSIS
by: I. N. Ozerova, et al.
Published: (2017-12-01)

The first experience of melatonin administration for correction of sleep disturbances in rheumatoid arthritis patients
by: A. E. Karateev, et al.
Published: (2004-08-01)

Uptake of cholesterol esters being a part of the different fractions of blood plasma lipoproteins by rats organs and tissues
by: L. M. Polyakov, et al.
Published: (2020-01-01)

VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY
by: E. P. Trukhacheva, et al.
Published: (2016-01-01)

High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology
by: N. N. Smirnova, et al.
Published: (2023-12-01)